CAS 170984-72-2: EGLU
Description:EGLU, or Eglin C, is a synthetic peptide with the CAS number 170984-72-2, primarily known for its role as a potent inhibitor of serine proteases. It is derived from the venom of the green mamba snake and exhibits a high degree of specificity towards various serine proteases, making it a valuable tool in biochemical research and potential therapeutic applications. EGLU is characterized by its unique amino acid sequence, which contributes to its stability and binding affinity. The peptide is typically used in studies related to blood coagulation, inflammation, and cancer, as it can modulate proteolytic activity in biological systems. Additionally, EGLU's structure allows for potential modifications to enhance its properties or target specific proteases more effectively. Its effectiveness and specificity make it a subject of interest in drug development and therapeutic interventions aimed at diseases involving dysregulated protease activity.
Formula:C7H13NO4
InChI:InChI=1S/C7H13NO4/c1-2-7(8,6(11)12)4-3-5(9)10/h2-4,8H2,1H3,(H,9,10)(H,11,12)/t7-/m0/s1
InChI key:InChIKey=QFYBYZLHPIALCZ-ZETCQYMHSA-N
SMILES:O=C(O)CCC(N)(C(=O)O)CC
- Synonyms:
- L-Glutamic acid, 2-ethyl-
- EGLU
- 2-Ethyl-L-glutamic acid
- (S)-α-Ethylglutamate
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | EGLU REF: 54-BUP02101CAS: 170984-72-2 | 99.98% | 1,955.00 €~4,220.00 € | Mon 21 Apr 25 |
![]() | EGLU REF: TM-T11165CAS: 170984-72-2 | 99.98% | 279.00 €~2,337.00 € | Tue 22 Apr 25 |
![]() | EGLU REF: 4Z-PG-3518CAS: 170984-72-2 | - - - | To inquire | Thu 24 Apr 25 |

Ref: 54-BUP02101
25mg | 1,955.00 € | ||
50mg | 2,547.00 € | ||
200mg | 4,220.00 € |

EGLU
Ref: TM-T11165
1mg | 279.00 € | ||
2mg | 414.00 € | ||
5mg | 685.00 € | ||
10mg | 938.00 € | ||
25mg | 1,444.00 € | ||
50mg | 1,882.00 € |

Ref: 4Z-PG-3518
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |